Plain-English translation of NCT01432847 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are collecting small skin biopsies and blood samples from people with inherited retinal diseases—like age-related macular degeneration, retinitis pigmentosa, and other conditions that cause progressive vision loss—as well as from healthy matched volunteers. These samples will be used to create special laboratory cells called induced pluripotent stem cells, which can be grown into eye cells in the lab. Scientists will then study these cells to understand why these diseases happen and to test drugs that might slow or stop vision loss.
Many inherited eye diseases damage the retina and cause blindness, but we still don't fully understand the underlying causes. By studying cells from people who actually have these diseases, researchers hope to discover how they develop and identify new medicines that could help prevent or treat them.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will visit the clinic once to have a small skin biopsy taken (a punch about the size of a pencil eraser) and provide a blood sample of about 30 milliliters (roughly 2 tablespoons). If you cannot provide blood or skin samples, you may instead provide a urine sample. The researchers will then use these cells to grow eye cells in the laboratory and study them over time. There are no ongoing visits or follow-up appointments required after your initial sample collection.
AI-generated summary from trial data · Oct 5, 2026 · Not medical advice
United States